A hematologist-oncologist is the primary doctor who treats acute myeloid leukemia (AML). This is a physician who specializes specifically in blood cancers, and they lead the decisions about your diagnosis, treatment plan, and long-term monitoring. But AML care rarely involves just one doctor. Because treatment is intensive and often requires weeks-long hospital stays, a full team of specialists typically works together from the start.
Your Lead Doctor: The Hematologist-Oncologist
A hematologist-oncologist has completed training in both hematology (blood disorders) and oncology (cancer treatment). This dual specialty matters for AML because the disease starts in the bone marrow and affects blood cell production, so your doctor needs deep expertise in both areas. They determine the specific subtype of your leukemia, select the treatment approach, manage chemotherapy, and coordinate with other specialists as needed.
If you’re being seen by a general oncologist in a smaller practice, that doctor can still manage your care, but ideally in collaboration with a leukemia specialist. Your local cancer doctor and a leukemia-focused hematologist-oncologist at a larger center can work together, which is especially useful if traveling to a major medical center isn’t practical for every appointment.
The Hematopathologist Behind Your Diagnosis
Before treatment starts, a specialist you may never meet in person plays a critical role. A hematopathologist is a doctor who studies blood cell diseases by examining samples of blood, bone marrow, and other tissues under a microscope. After your doctor takes blood and bone marrow samples, the hematopathologist confirms the AML diagnosis and identifies the specific genetic mutations driving your leukemia. This genetic profile directly shapes which treatments your hematologist-oncologist recommends, so the accuracy of this work is foundational to everything that follows.
When a Transplant Specialist Gets Involved
Many AML patients will need to see a transplant doctor, and the recommendation from the National Marrow Donor Program is to schedule that consultation as soon as AML is diagnosed, even if a transplant isn’t immediately needed. A transplant specialist (sometimes called a bone marrow transplant or cellular therapy physician) evaluates whether a stem cell transplant could improve your chances of a cure and helps identify potential donors early in the process.
A transplant consultation is especially urgent if your AML has a high risk of returning after initial chemotherapy, if your leukemia developed from a prior blood disorder like myelodysplastic syndrome, if it was caused by previous cancer treatment, or if the first round of chemotherapy doesn’t lead to remission. Younger patients with a closely matched donor who receive a transplant soon after diagnosis tend to have the best outcomes. Even when transplant isn’t part of the immediate plan, having that evaluation on file gives your team more options if the situation changes.
The Full Care Team
AML treatment, particularly intensive chemotherapy, often requires hospital stays of several weeks. During that time, you interact with a much broader group of professionals than just your lead oncologist. A typical multidisciplinary AML team includes:
- Advanced practice providers (nurse practitioners and physician assistants) who manage day-to-day care, adjust medications, and serve as your most frequent point of contact during hospitalization
- Oncology nurses who administer chemotherapy, monitor for side effects, and provide patient education
- Pharmacists who review drug interactions, help manage side effects, and educate you on what each medication does
- Infectious disease specialists who step in because AML and its treatment severely weaken the immune system, making infections a major risk
- Nutritionists who help maintain your strength and manage eating difficulties during treatment
- Physical and occupational therapists who work to prevent the muscle loss and deconditioning that come with extended hospital stays
- Nurse navigators and social workers who coordinate logistics like insurance, transportation, housing near treatment centers, and emotional support for both patients and caregivers
- Transplant coordinators who handle the complex scheduling and donor matching if a stem cell transplant is part of your plan
This isn’t a luxury setup reserved for major hospitals. Multidisciplinary coordination is considered essential for successful AML management because the disease and its treatment affect so many body systems simultaneously.
Palliative Care Specialists
Palliative care in AML doesn’t mean end-of-life care. These clinicians specialize in managing the physical and emotional burden of intensive treatment. During chemotherapy hospitalizations, palliative care providers can meet with patients multiple times per week to address pain, nausea, fatigue, anxiety, and the psychological weight of a serious diagnosis. Research from a randomized clinical trial found that AML patients who received early palliative care support during chemotherapy developed stronger coping strategies, suggesting this isn’t just comfort care but a meaningful part of treatment itself. Your oncology team can refer you to palliative care at any point, and it works alongside curative treatment rather than replacing it.
Academic Centers vs. Community Hospitals
One of the first decisions AML patients face is where to get treated. Large academic medical centers and NCI-designated cancer centers (there are 73 across 37 states and Washington, D.C.) offer the widest access to clinical trials and the most specialized leukemia teams. Each year, roughly 400,000 patients receive cancer diagnoses at NCI-designated centers, and thousands enroll in clinical trials through them.
That said, community cancer centers can deliver comparable results in certain situations. An analysis of older AML patients enrolled in clinical trials found no statistically significant difference in overall survival between community and academic centers after adjusting for patient characteristics. One-year survival was 43.9% at community centers compared to 35.7% at academic centers, and one-month mortality rates were also similar. The key factor was that these community patients were enrolled in clinical trials with standardized protocols, which likely leveled the playing field. If you’re treated at a community center, asking about available clinical trials is one of the most important steps you can take.
Finding the Right Specialist
If you’ve just been diagnosed, the single most useful step is confirming that your treating physician has specific experience with AML, not just general oncology or even general hematology. AML subtypes vary widely, and treatment has become increasingly tailored to the genetic profile of each patient’s disease. A doctor who treats AML regularly will be more familiar with the newer targeted therapies and with the nuances of deciding between intensive and less intensive approaches.
The Leukemia & Lymphoma Society maintains resources for locating blood cancer specialists, and NCI-designated cancer centers list their physicians by specialty area. If you’re already working with a local oncologist, asking for a second opinion at a leukemia-focused center doesn’t mean switching doctors. Many patients get their initial workup and treatment plan at a specialized center, then return closer to home for ongoing care with their community oncologist following that plan. Some practical questions worth raising at your first visit: What subtype of AML do I have? What’s the expected treatment timeline? Should I see a transplant specialist now? And are there clinical trials I’d be eligible for?